Skip to main content

Postoperative Management of Diabetes

  • Chapter
Surgical Intensive Care Medicine

Abstract

Diabetes mellitus is the most commonly encountered endocrinopathy in surgical and critically ill patients. Patients with diabetes are more likely to require surgical procedures than patients who do not have diabetes, and the number of patients with the disease (mainly type 2) continues to rise as the population ages (1). Diabetes, which is a disease of glucose dysregulation and carbohydrate intolerance, can be classified into four major types: type 1 (insulin dependent), type 2 (non-insulin dependent), gestational, and secondary (See Table 1) (2). Diabetes may result in acute and long-term systemic sequelae (See Table 2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. PetersA, Kerner W. Perioperative management of the diabetic patient. Exp Clin Endocrinol Diabetes 1995; 103: 213–8.

    Article  Google Scholar 

  2. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998; 21 (suppl 1): S5 - S19.

    Google Scholar 

  3. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999; 341: 1749–56.

    Article  PubMed  CAS  Google Scholar 

  4. Boulanger BR, Gann DS. Management of the trauma victim with pre-existing endocrine disease. Crit Care Clin 1994; 10: 537–54.

    PubMed  CAS  Google Scholar 

  5. Wass CT, Lanier WL. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc 1996; 71: 801–12.

    Article  PubMed  CAS  Google Scholar 

  6. Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab 1992; 18: 187–201.

    PubMed  CAS  Google Scholar 

  7. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999; 131: 281–303.

    PubMed  CAS  Google Scholar 

  8. Arem, R. Hypoglycemia associated with renal failure. Endocrinol Metab Clin North Am 1989; 18: 103–21.

    PubMed  CAS  Google Scholar 

  9. Comi RJ. Approach to acute hypoglycemia. Endocrinol Metab Clin North Am 1993; 22: 247–62.

    PubMed  CAS  Google Scholar 

  10. Fleckman AM. Diabetic ketoacidosis. Endocrinol Metab Clin North Am 1993; 22: 181–207.

    PubMed  CAS  Google Scholar 

  11. Guerin JM, Meyer P, Segrestaa JM. Hypothermia in diabetic ketoacidosis. Diabetes Care 1987; 10: 801–2.

    PubMed  CAS  Google Scholar 

  12. Faich GA, Fishbein HA, Ellis SE. The epidemiology of diabetic acidosis: a population-based study. Am J Epidemiol 1983; 117: 551–8.

    PubMed  CAS  Google Scholar 

  13. Ellis EN. Concepts of fluid therapy in diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic coma. Pediatr Clin North Am 1990; 37: 313–21.

    PubMed  CAS  Google Scholar 

  14. Katz MA. Hyperglycemia-induced hyponatremia: calculation of expected serum sodium depression. N Engl J Med 1973; 289: 843–4.

    Article  PubMed  CAS  Google Scholar 

  15. Riley LJ Jr, Cooper M, Narins RG. Alkali therapy of diabetic ketoacidosis: biochemical, physiologic, and clinical perspectives. Diabetes Metab Rev 1989; 5: 627–36.

    Article  PubMed  Google Scholar 

  16. Viallon A, Zeni F, Lafond P, Venet C, Tardy B, Page Y, Bertrand JC. Does bicarbonate therapy improve the management of severe diabetic ketoacidosis?. Crit Care Med 1999; 27: 2690–3.

    Article  PubMed  CAS  Google Scholar 

  17. Bello FA, Sotos JF. Cerebral oedema in diabetic ketoacidosis in children. Lancet 1990; 336: 64.

    Article  PubMed  CAS  Google Scholar 

  18. Duck SC, Weldon VV, Pagliara AS, Haymond MW. Cerebral edema complicating therapy for diabetic ketoacidosis. Diabetes 1976; 25: 111–5.

    Article  PubMed  CAS  Google Scholar 

  19. Rosenbloom AL. Intracerebral crises during treatment of diabetic ketoacidosis. Diabetes Care 1990; 13: 22–33.

    Article  PubMed  CAS  Google Scholar 

  20. Van der Meulen JA, Klip A, Grinstein S. Possible mechanism for cerebral oedema in diabetic ketoacidosis. Lancet 1987; 2: 306–8.

    Article  PubMed  Google Scholar 

  21. Basu A, Close CF, Jenkins D, Krentz AJ, Nattrass M, Wright AD. Persisting mortality in diabetic ketoacidosis. Diabet Med 1993; 10: 282–4.

    Article  PubMed  CAS  Google Scholar 

  22. Matz R. Hyperosmolar nonacidotic diabetes (HNAD). In: Porte D, Sherwin RS, eds. Ellenberg & Rifkin’s Diabetes Mellitus, 5th ed., Stamford, CT: Appleton & Lange 1997: 850.

    Google Scholar 

  23. Lorber D. Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am 1995; 79: 39–52.

    PubMed  CAS  Google Scholar 

  24. Clark CM Jr, Lee DA. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995; 332: 1210–7.

    Article  PubMed  Google Scholar 

  25. Vijan S, Hofer TP, Hayward RA. Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 1997; 127: 788–95.

    PubMed  CAS  Google Scholar 

  26. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837–53.

    Google Scholar 

  27. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–65.

    Google Scholar 

  28. Aronson D, Rayfield EJ, Chesebro JH. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction. Ann Intern Med 1997; 126: 296–306.

    PubMed  CAS  Google Scholar 

  29. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 1998; 339: 489–97.

    Article  PubMed  CAS  Google Scholar 

  30. Golan L, Birkmeyer JD, Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med 1999; 131: 660–7.

    PubMed  CAS  Google Scholar 

  31. Hogan K, Rusy D, Springman SR. Difficult laryngoscopy and diabetes mellitus. Anesth Analg 1988; 67: 1162–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Unger, B., Coursin, D.B. (2001). Postoperative Management of Diabetes. In: O’Donnell, J.M., Nácul, F.E. (eds) Surgical Intensive Care Medicine. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6645-5_33

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6645-5_33

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6647-9

  • Online ISBN: 978-1-4757-6645-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics